glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wink, K | 1 |
| Asselbergs, FW; Jessurun, GA; Tio, RA; van der Harst, P; van Gilst, WH | 1 |
2 review(s) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and Cardiovascular Diseases
| Article | Year |
|---|---|
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hypertension; Peptide Fragments; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2003 |
Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins.
Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peptide Fragments; Vasomotor System | 2005 |